Cargando…
Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification
Inflammatory bowel disease (IBD) represents a group of progressive disorders characterized by recurrent chronic inflammation of the gut. Ulcerative colitis and Crohn′s disease are the major manifestations of IBD. While our understanding of IBD has progressed in recent years, its etiology is far from...
Autores principales: | Titz, Bjoern, Gadaleta, Raffaella M., Lo Sasso, Giuseppe, Elamin, Ashraf, Ekroos, Kim, Ivanov, Nikolai V., Peitsch, Manuel C., Hoeng, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163330/ https://www.ncbi.nlm.nih.gov/pubmed/30223557 http://dx.doi.org/10.3390/ijms19092775 |
Ejemplares similares
-
Proteomics for systems toxicology
por: Titz, Bjoern, et al.
Publicado: (2014) -
Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
por: Titz, Bjoern, et al.
Publicado: (2016) -
Effects of Cigarette Smoke, Cessation, and Switching to Two Heat-Not-Burn Tobacco Products on Lung Lipid Metabolism in C57BL/6 and Apoe(−/−) Mice—An Integrative Systems Toxicology Analysis
por: Titz, Bjoern, et al.
Publicado: (2016) -
Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models
por: Martin, Florian, et al.
Publicado: (2014) -
New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies
por: Longo, Serena, et al.
Publicado: (2020)